GHK-Cu vs Matrixyl: Research Profile Comparison
GHK-Cu and Matrixyl are both well-established in dermal-research literature and both appear in commercial cosmetic formulations, which sometimes leads to them being treated as equivalent. Structurally they are unrelated compounds.
| GHK-Cu | Matrixyl (Palmitoyl Pentapeptide-4) | |
|---|---|---|
| Structure | Tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper | Palmitic acid conjugated to a synthetic five-amino-acid sequence |
| Class | Copper peptide complex, naturally occurring in human plasma | Lipidated (palmitoylated) synthetic pentapeptide |
| Primary research focus | Extracellular matrix remodelling, wound-healing and anti-inflammatory research | Collagen-signalling research in dermal fibroblast models |
| Copper dependency | Mechanism is copper-dependent — the copper ion is integral to its proposed activity | No copper involvement; mechanism is independent of metal-ion binding |
| Typical research format | Supplied as a lyophilised copper-complexed peptide | Supplied as a lyophilised lipidated peptide |
Takeaway
The overlap is functional (both appear in dermal-research and cosmetic-formulation literature), not structural — GHK-Cu is a copper-dependent tripeptide complex, Matrixyl is an unrelated palmitoylated pentapeptide. Reported research effects are not necessarily comparable in mechanism, magnitude, or evidence base.
Research-profile comparison for laboratory reference only — not a usage, dosing, or stacking guide. See our legal & compliance hub for the regulatory position on either compound.